⌘K

Login Start Free

Home/Filings/4/0001372514-25-000029

4//SEC Filing

Parsons Erin 4

Accession 0001372514-25-000029

CIK 0001372514other

View on SEC.gov Company Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 8:15 PM ET

Size

5.5 KB

Accession

0001372514-25-000029

Insider Transaction Report

Form 4

Period: 2025-04-01

KIORA PHARMACEUTICALS INCKPRX

Director

Transactions

Award
Stock Option (right to buy)
2025-04-01+20,000→ 20,000 total
Exercise: $2.93From: 2026-04-01Exp: 2035-04-01→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on April 1, 2026.

Documents

1 file

4
wk-form4_1743639351.xmlPrimary
FORM 4

Issuer

KIORA PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001895795

Filing Metadata

Form type: 4
Filed: Apr 1, 8:00 PM ET
Accepted: Apr 2, 8:15 PM ET
Size: 5.5 KB

View on SEC.gov